DNA Genotek, a Subsidiary of OraSure, Launches HEMAcollect™●PROTEIN for Proteomic Research

Reuters
07/10
DNA Genotek, a Subsidiary of OraSure, Launches HEMAcollect™●PROTEIN for Proteomic Research

OraSure Technologies, Inc. has launched a new product through its subsidiary, DNA Genotek, to advance proteomic research. The product, HEMAcollect™●PROTEIN, is an evacuated blood collection tube designed to preserve and stabilize plasma proteins in whole blood for up to seven days. This innovation, intended for research use, aims to overcome limitations of conventional blood collection tubes by facilitating storage and transport of blood samples at ambient temperature. This development promises to deliver operational and financial efficiencies to proteomic researchers and enhance the quality of data generated. The device is compatible with various proteomic technologies, including mass spectrometry and immunoassays, and is applicable in multiple research areas such as oncology and neurology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OraSure Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9491972-en) on July 10, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10